|
QLT ends trials for prostate cancer drug after poor results Craig Wong, Canadian Press, Vancouver Sun February 15, 2006
Executive Decision: Just what the doctor ordered for growing pains Leonard Zehr, The Globe and Mail February 11, 2006
Aspreva revenue rockets to $76.5m: Victoria biotech firm even more bullish for 2006, projecting revenues over $175 million Gillian Shaw, Vancouver Sun February 9, 2006
Aspreva posts $24.3-million profit Canadian Press, The Province February 9, 2006
Pace of iCo unmatched by biotech competitors Gillian Shaw, Vancouver Sun February 8, 2006
Flexibility, vision key for establishing partnerships Karen Pihl-Carey, BioWorld Today February 8, 2006
AnorMED boardroom battle heats up Gillian Shaw, Vancouver Sun February 8, 2006
Biotech deals: focusing on pharma relationships Karen Pihl-Carey, BioWorld Today February 7, 2006
Pharmaceutical conference 'an incubator' for future deals Gillian Shaw, Vancouver Sun February 7, 2006
Aspreva shares spike on Q4 revenues Gillian Shaw, Vancouver Sun February 3, 2006 |